CS Analytical Expands Service Offering for New USP 382 Testing Requirements

With our unique focus on container and package system testing, expanding our service offering to directly address all aspects of the new USP 382 requirements is a natural progression for CS Analytical's service line. We are aligned with the USP in encouraging early adoption and look forward to working with clients to meet these new regulatory requirements.

CLIFTON, N.J., Jan. 25, 2023 /PRNewswire-PRWeb/ -- CS Analytical Laboratory, the world's only FDA regulated contract laboratory exclusively dedicated to providing regulatory solutions and qualification testing services specifically for drug product and medical device container systems, is pleased to announce that it has expanded its service offering to directly address all aspects of the new USP 382 General Chapter Elastomeric Closure Functionality in Injectable Pharmaceutical Packaging/Delivery Systems. While requirements of these new testing requirements will not become official until December 1, 2025, the USP has granted a provision and encourages early adoption of the new standard.